These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 76257)
1. Identity of specific macrophage-active human lymphokines. Block LH; Jaksche H; Bamberger S; Ruhenstroth-Bauer G Lancet; 1978 Apr; 1(8066):718-9. PubMed ID: 76257 [No Abstract] [Full Text] [Related]
2. Differences between macrophage migration inhibitions by lymphokines and muramyl dipeptide (MDP) or lipopolysaccharide (LPS): migration enhancement by lymphokines. Nagao S; Tanaka A; Onozaki K; Hashimoto T Cell Immunol; 1982 Jul; 71(1):1-11. PubMed ID: 6754096 [No Abstract] [Full Text] [Related]
3. [Lymphokines, with special reference to skin reactive factor (SRF) (author's transl)]. Aoki T Rinsho Byori; 1981 Dec; 29(12):1223-7. PubMed ID: 7040741 [No Abstract] [Full Text] [Related]
4. [The mechanism of the in vitro migration inhibition test (author's transl)]. Sabioncello A; Dekaris D Lijec Vjesn; 1978 Sep; 100(9):535-42. PubMed ID: 368478 [No Abstract] [Full Text] [Related]
5. Interaction of Lotus-tetragonolobus Lectin (LTL) and an MIF-like factor with guinea-pig macrophages. I. Effects on macrophage migration inhibition and receptor-binding studies. Fahlbusch B; Wollweber L; Drössler K; Scherbaum I; Zschiesche W Immunobiology; 1982 Aug; 162(3):251-64. PubMed ID: 6752005 [TBL] [Abstract][Full Text] [Related]
6. Biological and clinical significance of macrophage electrophoretic mobility (MEM) test in tumor immunity. Nakajima T; Isojima K; Iwaguchi T Cell Mol Biol Incl Cyto Enzymol; 1979; 25(5):355-61. PubMed ID: 394842 [No Abstract] [Full Text] [Related]
7. Production of an antibody against guinea pig MIF. II. Analysis of the antibody-reacting material using radiolabeled lymphokines. Onozaki K; Haga S; Miura K; Homma Y; Hashimoto T Cell Immunol; 1980 Oct; 55(2):465-75. PubMed ID: 7000379 [No Abstract] [Full Text] [Related]
8. Assay of human lymphokines in vitro. Evidence for a migration stimulation factor (MStF) which interferes with the macrophage migration inhibition assay. Aaskov JG; Anthony HM Aust J Exp Biol Med Sci; 1976 Dec; 54(6):527-39. PubMed ID: 800335 [TBL] [Abstract][Full Text] [Related]
9. Genetic control of lymphokine production as assessed by macrophage migration inhibition and lymphocyte proliferation. Waxman FJ; Hinrichs DJ; Maurer PH; Baram P Cell Immunol; 1980 Mar; 50(1):1-18. PubMed ID: 6994892 [No Abstract] [Full Text] [Related]
10. An ELISA method for quantitation of macrophage migration from agarose microdroplets. Peck R J Immunol Methods; 1983 Nov; 64(1-2):179-87. PubMed ID: 6358361 [TBL] [Abstract][Full Text] [Related]
11. Influence of autologous sera in some dermatoses on spontaneous migration of leukocytes and macrophages taken from mouse spleens. Miklaszewska M Mater Med Pol; 1978; 10(2):101-6. PubMed ID: 359946 [No Abstract] [Full Text] [Related]
12. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors. Preece AW; Light PA Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199 [TBL] [Abstract][Full Text] [Related]
13. Migration inhibition and stimulation factors produced from peripheral blood lymphocyte cultures of sensitised guinea pigs. Matsui Y; Oshima S Asian Pac J Allergy Immunol; 1985 Dec; 3(2):151-5. PubMed ID: 3907650 [TBL] [Abstract][Full Text] [Related]
14. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes. Ruthlomnitzer ; Rabson AR; Koornhof HJ Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578 [TBL] [Abstract][Full Text] [Related]